Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
63,129
-
Share change
-
+40,244
-
Total reported value
-
$26,000
-
Price per share
-
$0.43
-
Number of holders
-
5
-
Value change
-
+$16,758
-
Number of buys
-
4
-
Number of sells
-
1
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2015
As of 30 Jun 2015,
IGC Pharma, Inc. - COM NEW (IGC) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,129 shares.
The largest 5 holders included
KCG Holdings, Inc., Citadel Advisors LLC, UBS Group AG, BANK OF AMERICA CORP /DE/, and LADENBURG THALMANN FINANCIAL SERVICES INC.
This page lists
5
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.